Caring for Cancer Survivors: More Than Just Checking the Blood Pressure and Measuring the Ejection Fraction

References

• Floyd JD , NguyenDT, LobinsRL, BashirQ, DollDC, PerryMC . Cardiotoxicity of cancer therapy . J. Clin. Oncol.23 ( 30 ), 7685 – 7696 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Swain SM , WhaleyFS, EwerMS . Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials . Cancer97 ( 11 ), 2869 – 2879 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Lipshultz SE , LipsitzSR, MoneSMet al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer . N. Engl. J. Med.332 ( 26 ), 1738 – 1743 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Nysom K , HolmK, LipsitzSRet al. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia . J. Clin. Oncol.16 ( 2 ), 545 – 550 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Mulrooney DA , YeazelMW, KawashimaTet al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort . BMJ339, b4606 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Seidman A , HudisC, PierriMKet al. Cardiac dysfunction in the trastuzumab clinical trials experience . J. Clin. Oncol.20 ( 5 ), 1215 – 1221 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Guglin M , HartlageG, ReynoldsC, ChenR, PatelV . Trastuzumab-induced cardiomyopathy: not as benign as it looks? A retrospective study . J. Card. Fail.15 ( 8 ), 651 – 657 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hancock SL , TuckerMA, HoppeRT . Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease . JAMA270 ( 16 ), 1949 – 1955 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Darby SC , EwertzM, McgalePet al. Risk of ischemic heart disease in women after radiotherapy for breast cancer . N. Engl. J. Med.368 ( 11 ), 987 – 998 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Landier W , BhatiaS, EshelmanDAet al. Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up Guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline . J. Clin. Oncol.22 ( 24 ), 4979 – 4990 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Armstrong GT , OeffingerKC, ChenYet al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer . J. Clin. Oncol.31 ( 29 ), 3673 – 3680 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Brouwer CA , PostmaA, HooimeijerHLet al. Endothelial damage in long-term survivors of childhood cancer . J. Clin. Oncol.31 ( 31 ), 3906 – 3913 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Van Leeuwen-Segarceanu EM , DorresteijnLD, VogelsOJ, BiesmaDH, BosWJ . Arterial stiffness is increased in Hodgkin lymphoma survivors treated with radiotherapy . Leuk. Lymphoma54 ( 8 ), 1734 – 1741 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Malhotra J , TonorezosES, RozenbergMet al. Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia . J. Lipid Res.53 ( 12 ), 2747 – 2754 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Cardinale D , SandriMT, ColomboAet al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy . Circulation109 ( 22 ), 2749 – 2754 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Morris PG , ChenC, SteingartRet al. Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib . Clin. Cancer. Res.17 ( 10 ), 3490 – 3499 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ky B , PuttM, SawayaHet al. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab . J. Am. Coll. Cardiol.63 ( 8 ), 809 – 816 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lipshultz SE , LandyDC, Lopez-MitnikGet al. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy . J. Clin. Oncol.30 ( 10 ), 1050 – 1057 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Brouwer CA , PostmaA, VonkJMet al. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer . Eur. J. Cancer47 ( 16 ), 2453 – 2462 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Sanchez OA , JacobsDRJr, BahramiHet al. Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis . J. Hypertens.33 ( 5 ), 966 – 974 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Greenland P , AlpertJS, BellerGAet al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines . J. Am. Coll. Cardiol.56 ( 25 ), e50 – 103 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Meeske KA , SiegelSE, GilsanzVet al. Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation . Pediatr. Blood Cancer53 ( 4 ), 615 – 621 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Smith WA , LiC, NottageKAet al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study . Cancer120 ( 17 ), 2742 – 2750 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tonorezos ES , RobienK, Eshelman-KentDet al. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia . Cancer Causes Control24 ( 2 ), 313 – 321 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ridker PM , DanielsonE, FonsecaFAet al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein . N. Engl. J. Med.359 ( 21 ), 2195 – 2207 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Duprez DA . Is vascular stiffness a target for therapy?Cardiovasc. Drugs Ther.24 ( 4 ), 305 – 310 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mahmud A , FeelyJ . Antihypertensive drugs and arterial stiffness . Expert Rev. Cardiovasc. Ther.1 ( 1 ), 65 – 78 ( 2003 ).
   PubMedGoogle Scholar